All Cancer articles – Page 38
-
Supplements
Value in Healthcare Awards: Implementation of IT to Support Healthcare Business Efficiency
Value in Healthcare Awards winners for 2015
-
-
CommentCuts in cancer spending expose a funding challenge
There will be tough choices over cash and cancer
-
NewsHigh profile treatments cut from cancer drugs fund
High profile cancer treatments including Roche’s Kadcyla and Avastin are to be removed from the cancer drugs fund.
-
-
NewsDrug pricing deal change 'cuts NHS England's ability to provide care'
NHS England faces a ‘direct cut’ in its ability to provide care to patients as a result of a change to the deal that caps the price the government pays for branded medicines, a senior health economist has said.
-
NewsBacklash expected over cancer drugs delisting
Talks are under way to identify high profile treatments to be removed from the cancer drugs fund in the coming months, HSJ has learned.
-
HSJ LocalPolice clear Colchester trust of data ‘manipulation’ claims
PERFORMANCE: Colchester Hospital University Foundation Trust has been cleared of wrongdoing, following a police investigation into allegations of cancer data ‘manipulation’.
-
NewsDemand for elective care highest in seven years
The number of patients waiting to start treatment has hit the highest point in seven years, according to the latest data from NHS England.
-
NewsStruggling emergency care systems to get winter buddies
A buddy system for poorly performing urgent and emergency care systems will be introduced this winter in an attempt to help the ‘most challenged’ areas.
-
CommentOnly together can we beat cancer
Public-private collaboration is vital to win the war on cancer
-
NewsSpecialist radiotherapy overhaul could result in decommissioning
An overhaul of specialist radiotherapy services could result in a number of existing providers being decommissioned, a consultation paper published by NHS England suggests.
-
HSJ LocalLast Staffordshire trust pulls out of £690m cancer consortium
COMMERCIAL: The main acute provider in Staffordshire has pulled out of a consortium bid to take on a £687m, 10 year prime provider contract for cancer services.
-
CommentThe cancer strategy has laid down a challenge to government
To what extent will the government act on the taskforce’s recommendations?
-
NewsBreast cancer drug remains on CDF after ‘significant concessions’
A breast cancer drug will remain on the list of treatments patients can access through the cancer drugs fund after the manufacturer made ‘significant concessions’ on the price.
-
NewsNHS England unveils revamp of cancer drugs fund
The cancer drugs fund should become a ‘managed access’ fund, which would pay for new drugs for a set period before they are approved or rejected by NICE, NHS England has said.
-
NewsReview to consider ‘cancer drugs fund’ for innovative medicines
The government’s accelerated access review will look at whether the principle of the cancer drugs fund could be extended to non-cancer treatments, its chair has said.
-
News'Massive relief' over NHS England decision on rare condition drug
A drug at the centre of a row over preventable deaths and policy delays could become routinely available on the NHS, it has emerged.
-
NewsCancer commissioning overhaul could save 30,000 lives
The NHS can save 30,000 more lives a year by overhauling cancer commissioning and treatment funding, a national taskforce has said.
-
NewsUpdated: NHS England halts cancer drugs working group
A group tasked by NHS England to examine how cancer drugs can be evaluated and commissioned in future has had its work ‘paused’ after just six months in operation.